South Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2012 (SA)

South Australia South Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2012 under the South Australian Public Health Act 2011

Contents 1 Short title 3 Interpretation 4 Notifiable conditions 5 Controlled notifiable conditions 5A Prescribed classes of persons (section 64(1)(c) of Act) 5B Exemption from notification requirements 6 Corresponding law Legislative history

1—Short title These regulations may be cited as the South Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2012. 3—Interpretation In these regulations— Act means the South Australian Public Health Act 2011; adverse event following immunisation or AEFI means any untoward medical occurrence that follows immunisation (whether or not the occurrence has a causal relationship with the vaccine); Australian Immunisation Handbook means The Australian Immunisation Handbook published by the Commonwealth Department of Health (as in force from time to time); Australian Register of Therapeutic Goods means the register maintained under section 9A of the Therapeutic Goods Act 1989 of the Commonwealth; notifiable adverse event following immunisation or notifiable AEFI means an AEFI that is not a very common or common AEFI; point‑of‑care test means a test included on the Australian Register of Therapeutic Goods that is performed on a person by a medical practitioner, or a person on behalf of a medical practitioner, at the time of the person's consultation (however described) with the medical practitioner; very common or common adverse event following immunisation or very common or common AEFI means an AEFI that is listed as a very common or common adverse event in the Australian Immunisation Handbook or in clinical advice relating to adverse events published by the Australian Technical Advisory Group on Immunisation (ATAGI) established by the Commonwealth Government. 4—Notifiable conditions For the purposes of section 63 of the Act, the following diseases or medical conditions are declared to be notifiable conditions: Anthrax Arbovirus infection Barmah Forest virus infection Botulism Brucellosis Campylobacter infection Candida auris Carbapenemase-producing Enterobacterales (CPE) Chancroid Chikungunya virus infection Chlamydia trachomatis (sexually transmitted infection only) Cholera Coronavirus Disease 2019 (COVID-19) Creutzfeldt-Jakob disease Cryptosporidiosis Dengue virus infection Diphtheria Donovanosis Food Poisoning Gonococcal infection Haemolytic‑Uraemic Syndrome (HUS) Haemophilus influenzae infection (invasive) Hendra virus infection Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Human Immunodeficiency Virus infection (HIV) Influenza Influenza (avian in humans) Influenza (pandemic) Invasive group A streptococcal disease Japanese Encephalitis virus infection Legionellosis Leprosy Leptospirosis Listeriosis Lyssavirus infection (including rabies, Australian bat lyssavirus and other lyssavirus infections) Malaria Measles Meningococcal disease (invasive) Middle East respiratory syndrome coronavirus infection (MERS‑CoV) Monkeypox virus infection Mumps Murray Valley Encephalitis virus infection Mycobacterial infection (non‑tuberculous) Notifiable adverse event following immunisation Paratyphoid (Salmonella Paratyphi infection) Pertussis Plague Pneumococcal disease (invasive) Poliovirus infection Psittacosis / Ornithosis Q Fever Respiratory syncytial virus (RSV) Rheumatic fever Rheumatic heart disease Ross River virus infection Rotavirus Rubella and Congenital Rubella Syndrome Salmonella infection Severe Acute Respiratory Syndrome (SARS) Severe Acute Respiratory Syndrome Coronavirus 2 infection (SARS-CoV-2) Shiga toxin producing Escherichia coli infection (STEC) Shigella infection Smallpox Syphilis and Congenital Syphilis Tetanus Thrombotic Thrombocytopaenic Purpura (TTP) Tuberculosis Tularaemia Typhoid (Salmonella Typhi infection) Varicella‑Zoster virus infection Vibrio parahaemolyticus infection Viral Haemorrhagic Fever West Nile virus infection (including Kunjin variant) Yellow Fever Yersiniosis. 5—Controlled notifiable conditions For the purposes of section 70 of the Act, the following diseases or medical conditions are declared to be controlled notifiable conditions: Cholera Coronavirus Disease 2019 (COVID-19) Diphtheria Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Human Immunodeficiency Virus infection (HIV) Influenza (avian in humans) Influenza (pandemic) Measles Middle East respiratory syndrome coronavirus infection (MERS‑CoV) Plague Poliovirus infection Salmonella infection Severe Acute Respiratory Syndrome (SARS) Severe Acute Respiratory Syndrome Coronavirus 2 infection (SARS-CoV-2) Shigella infection Smallpox Tuberculosis Viral Haemorrhagic Fever Yellow Fever. 5A—Prescribed classes of persons (section 64(1)(c) of Act) (1) For the purposes of section 64(1)(c) of the Act, a registered health practitioner of a class determined by the Minister under regulation 18(3) of the Controlled Substances (Poisons) Regulations 2011 who— (a) has successfully completed a training program approved by the Minister for the purposes of regulation 18(3) of those regulations; and (b) is authorised to administer vaccines as part of an immunisation program delivered under regulation 18(3) of those regulations, is a person of a prescribed class, but only in respect of a suspicion that a person is suffering, or has died from, a notifiable AEFI. (2) A registered health practitioner of a class prescribed under subregulation (1) who suspects that a person is suffering from a notifiable AEFI is not required to make a report under section 64(1) of the Act with respect to that case if the practitioner knows or reasonably believes that a report has already been made to the Chief Public Health Officer by a medical practitioner or another registered health practitioner of a class prescribed under subregulation (1). (3) For the purposes of section 64(10)(c) of the Act, the responsible person for a registered health practitioner of a class prescribed under subregulation (1) is the registered health practitioner. 5B—Exemption from notification requirements (1) Pursuant to section 109(2)(t) of the Act, a medical practitioner is exempt from the application of section 64(1) of the Act— (a) in respect of a suspicion (other than a suspicion formed on the basis of a point‑of‑care test) that a person has a designated notifiable condition; or (ab) in respect of a suspicion formed on the basis of a point‑of‑care test that a person has a designated notifiable condition if the medical practitioner knows or reasonably believes that a report has already been made to the Chief Public Health Officer by a pathology service; or (b) if the medical practitioner suspects that a person is suffering from a notifiable AEFI and knows or reasonably believes that a report has already been made to the Chief Public Health Officer by another medical practitioner or registered health practitioner of a class prescribed under regulation 5A(1). (2) In this regulation— designated notifiable condition means— (a) Coronavirus Disease 2019 (COVID‑19); or (b) Influenza; or (c) Respiratory syncytial virus (RSV); or (d) Severe Acute Respiratory Syndrome Coronavirus 2 infection (SARS‑CoV‑2); or (e) Chlamydia trachomatis (sexually transmitted infection only), but only in relation to a person who is of or over the age of 17 years. 6—Corresponding law For the purpose of the definition of corresponding law in section 83(1) of the Act, the following are declared to be corresponding laws: Health Act 1911 of Western Australia Notifiable Diseases Act 1981 of the Northern Territory Public Health Act 1997 of the Australian Capital Territory Public Health Act 2010 of New South Wales Public Health Act 2005 of Queensland Public Health Act 1997 of Tasmania Public Health and Wellbeing Act 2008 of Victoria.